Philips respiratory devices recall classified as most serious by USFDA Ruchika Sharma19 Feb 2023 11:30 AM ISTUS: The U.S. Food and Drug Administration (FDA) has classified the recall of Dutch medical devices maker Philips' (PHG.AS) respiratory machines...
CDSCO nod to medical smartwatch CardiacSense Ruchika Sharma18 Feb 2023 11:00 AM IST"CardiacSense is one such device that will enable doctors and hospitals to monitor patients 24/7 who have recently undergone major surgeries or those...
Alembic Pharma Karkhadi facility gets EIR from USFDA Ruchika Sharma17 Feb 2023 1:00 PM ISTVadodara: Alembic Pharma has announced that the Company has received an Establishment Inspection Report (EIR) from the US Food and Drug...
Lupin gets USFDA EIR for Nagpur facility Ruchika Sharma17 Feb 2023 11:36 AM ISTMumbai: Global pharma major Lupin Limited today announced that the company has received the Establishment Inspection Report (EIR) from the United...
Zydus Lifesciences Sirolimus Tablets bags USFDA okay Ruchika Sharma17 Feb 2023 10:00 AM ISTThe drug will be manufactured at the group's formulation manufacturing facility at Moraiya.
USFDA nod to Zydus Lifesciences hypertension drug Ruchika Sharma15 Feb 2023 3:51 PM ISTThe drug will be manufactured at the group’s formulation manufacturing facility at SEZ, Ahmedabad.
Zydus Lifesciences bags tentative USFDA nod for Canagliflozin Tablets Ruchika Sharma15 Feb 2023 2:15 PM ISTThe drug will be manufactured at the group's formulation manufacturing facility at Moraiya.
Aurobindo Pharma Telangana facility gets VAI classification from USFDA Ruchika Sharma15 Feb 2023 12:15 PM ISTNew Delhi: Aurobindo Pharma has announced that the company has received Voluntary Action Indicated (VAI) from the US health regulator for its...
Caplin Steriles gets USFDA nod for Carboprost Tromethamine Injection Ruchika Sharma14 Feb 2023 1:15 PM ISTCarboprost Tromethamine Injection USP is an oxytocic, indicated for the treatment of postpartum hemorrhage due to uterine atony.
Natco Pharma announces submission of ANDA with USFDA for generic version of Olaparib Tablets Ruchika Sharma13 Feb 2023 12:25 PM ISTOlaparib is indicated primarily for certain forms of ovarian, breast, pancreatic and prostrate cancer.
Biocon partner Viatris gets Complete Response Letter from USFDA for Bevacizumab license application Ruchika Sharma13 Feb 2023 11:13 AM ISTBevacizumab is a medication used to treat a number of types of cancers and a specific eye disease.
Regeneron Pharma gets USFDA nod for EYLEA Injection to treat preterm infants with retinopathy of prematurity Ruchika Sharma12 Feb 2023 3:00 PM ISTEYLEA is a VEGF inhibitor formulated as an injection for the eye.
